» Authors » John Gill

John Gill

Explore the profile of John Gill including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 166
Citations 6484
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cruz P, Lam J, Abdalla J, Bell S, Bytyci J, Brosh-Nissimov T, et al.
Vaccines (Basel) . 2025 Jan; 13(1). PMID: 39852798
Safeguarding patients from emerging infectious diseases demands strategies that prioritise patient well-being and protection. Immunobridging is an established trial methodology which has been increasingly employed to ensure patient protection and...
2.
Shamseddin M, Paraskevas S, Mainra R, Maru K, Piggott B, Jagusic D, et al.
Can J Kidney Health Dis . 2024 Dec; 11:20543581241306811. PMID: 39735689
Purpose: Highly sensitized patients (HSPs) with kidney failure have limited access to kidney transplantation and poorer post-transplant outcomes. Prioritizing HSPs in kidney allocation systems and expanding the pool of deceased...
3.
Perera D, Li E, van der Meer F, Lynch T, Gill J, Church D, et al.
bioRxiv . 2024 Oct; PMID: 39416208
Modern sequencing instruments bring unprecedented opportunity to study within-host viral evolution in conjunction with viral transmissions between hosts. However, no computational simulators are available to assist the characterization of within-host...
4.
Pantazis N, Sabin C, Grabar S, Van Der Valk M, Jarrin I, van Sighem A, et al.
Lancet HIV . 2024 Aug; 11(10):e660-e669. PMID: 39186940
Background: Understanding the reasons for and consequences of bodyweight change in people living with HIV initiating antiretroviral therapy (ART) is crucial to optimising long-term health and wellbeing. We aimed to...
5.
Solera J, Ferreira V, Cervera C, Hosseini-Moghaddam S, Gill J, Shalhoub S, et al.
Transplantation . 2024 Aug; 109(3):527-535. PMID: 39160648
Background: There are few interventional studies using CMV cell-mediated immunity (CMI) to guide antiviral prophylaxis. We assessed the Quantiferon-CMV (QTF-CMV) assay to guide CMV prophylaxis duration in high-risk organ transplant...
6.
Halloran P, Madill-Thomsen K, Bohmig G, Bromberg J, Budde K, Barner M, et al.
Am J Transplant . 2024 Aug; 25(1):72-87. PMID: 39117038
Most kidney transplant patients who undergo biopsies are classified as having no rejection based on consensus thresholds. However, we hypothesized that because these patients have normal adaptive immune systems, T...
7.
Saeed S, Thomas T, Dinh D, Moodie E, Cox J, Cooper C, et al.
Open Forum Infect Dis . 2024 May; 11(5):ofae239. PMID: 38798898
Background: The cascade of care, commonly used to assess HIV and hepatitis C (HCV) health service delivery, has limitations in capturing the complexity of individuals' engagement patterns. This study examines...
8.
Ylitalo K, Cox W, Janda-Thomte K, Walter K, Gill J, Hess B
Transl Behav Med . 2024 Apr; 14(6):319-329. PMID: 38642402
The "Food as Medicine" (FAM) movement encourages public health and medical professionals to recognize the importance of dietary patterns and food access. The purpose of this work was to describe...
9.
Tran J, Alrajhi I, Chang D, Sherwood K, Keown P, Gill J, et al.
Front Genet . 2024 Apr; 15:1383220. PMID: 38638120
The optimal immunosuppression management in patients with a failed kidney transplant remains uncertain. This study analyzed the association of class II HLA eplet mismatches and maintenance immunosuppression with allosensitization after...
10.
Dobrer S, Sherwood K, Hirji I, Lan J, Gill J, Matic N, et al.
Front Immunol . 2024 Feb; 14:1302627. PMID: 38361528
Background: Despite advances in clinical management, cytomegalovirus (CMV) infection remains a serious complication and an important cause of morbidity and mortality following kidney transplantation. Here, we explore the importance of...